NOVEL 2-SUBSTITUTED TIAZOLE-4-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND USE AS PHARMACEUTICALS
申请人:Bothe Ulrich
公开号:US20090149517A1
公开(公告)日:2009-06-11
The present invention relates to 2-substituted thiazole-4-carboxamide derivatives of the formula (I), the use thereof as medicament for the treatment of various disorders, and processes for the preparation thereof
Novel 2-arylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals
申请人:Ulrich BOTHE
公开号:US20090163486A1
公开(公告)日:2009-06-25
The present invention relates to 2-arylthiazole-4-carboxamide derivatives of the formula (I), the use thereof as medicament for the treatment of various disorders, and processes for the preparation thereof
2-arylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals
申请人:Bayer Pharma Aktiengesellschaft
公开号:US08163739B2
公开(公告)日:2012-04-24
The present invention relates to 2-arylthiazole-4-carboxamide derivatives of the formula (I), the use thereof as medicament for the treatment of various disorders, and processes for the preparation thereof
2-hetarylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals
申请人:Bayer Pharma Aktiengesellschaft
公开号:US08148411B2
公开(公告)日:2012-04-03
The present invention relates to 2-hetarylthiazole-4-carboxamide derivatives of the formula (I), the use thereof as medicament for the treatment of various disorders, and processes for the preparation thereof
Neue 2-Hetarylthiazol-4-carbonsäureamid-Derivative, deren Herstellung und Verwendung als Arzneimittel
申请人:Bayer Schering Pharma Aktiengesellschaft
公开号:EP2070924A1
公开(公告)日:2009-06-17
Die vorliegende Erfindung betrifft 2-Hetarylthiazol-4-carbonsäureamid-Derivate der Formel (I), deren Verwendung als Medikament zur Behandlung verschiedener Erkrankungen, sowie Verfahren zur deren Herstellung